Emisphere Techonologies and AAIPharma form alliance

According to Emisphere, the Eligen technology is a unique and improved delivery method for therapeutic molecules and nutritional supplements. The key benefit of Eligen technology is that it improves the ability of the body to absorb small and large molecules.

The Eligen technology can be applied to oral administration or other routes of administration other than oral, such as buccal, rectal, inhalational, intra-vaginal or transdermal, said Emisphere.

Michael Novinski, president and CEO of Emisphere, said: “This relationship expands Emisphere’s access to new therapeutic candidates for its Eligen technology, which potentially could lead to new products for Emisphere’s pipeline and to new alliance agreements as well.”